02216.HK
Broncus Holding Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 0.64
−0.78%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.9M | 174.0K | 8.1M | 10.3M | 9.4M |
| Cost of Revenue | 5.9M | 1.1M | 2.0M | 3.0M | 2.1M |
| Gross Profit | 2.0M | (917.0K) | 6.1M | 7.2M | 7.3M |
| Operating Expenses | |||||
| R&D Expense | 14.3M | 7.8M | 11.5M | 20.2M | 19.2M |
| SG&A Expense | 32.2M | 15.7M | 15.8M | 20.4M | 20.4M |
| General & Admin Expense | 11.0M | 7.4M | 7.3M | 8.9M | 9.2M |
| Selling & Marketing Expense | 12.7M | 8.0M | 8.5M | 11.5M | 11.2M |
| Other Expenses | — | — | 1.4M | (121.0K) | 438.0K |
| Total Operating Expenses | 46.4M | 23.5M | 28.6M | 40.4M | 40.0M |
| Cost and Expenses | 52.3M | 24.6M | 30.6M | 43.5M | 42.1M |
| Operating Income (EBIT) | (44.5M) | (24.4M) | (22.5M) | (33.2M) | (32.7M) |
| Non-Operating | |||||
| Interest Income | 13.0M | 5.5M | 6.5M | 6.0M | 2.6M |
| Interest Expense | 8.0K | 4.0K | 84.0K | 163.0K | 98.0K |
| Net Interest Income | 13.0M | 5.5M | 6.5M | 5.9M | 2.5M |
| Other Non-Op Income/Expense | 11.1M | 6.5M | 7.2M | 5.1M | 4.7M |
| Non-Operating Income (excl Interest) | — | — | (4.6M) | (5.3M) | (3.8M) |
| EBT (Pre-Tax Income) | (33.4M) | (17.9M) | (15.3M) | (28.1M) | (28.0M) |
| Income Tax Expense | — | 1.0K | 3.0K | 3.0K | 3.0K |
| Bottom Line | |||||
| Net Income | (33.4M) | (17.9M) | (15.3M) | (28.1M) | (28.0M) |
| Earnings from Cont. Ops | (33.4M) | (17.9M) | (15.3M) | (28.1M) | (28.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (33.4M) | (17.9M) | (15.3M) | (28.1M) | (28.0M) |
| Per Share | |||||
| Basic EPS | (HK$0.07) | (HK$0.04) | (HK$0.03) | (HK$0.06) | (HK$0.06) |
| Diluted EPS | (HK$0.07) | (HK$0.04) | (HK$0.03) | (HK$0.06) | (HK$0.06) |
| Revenue Per Share | HK$0.02 | HK$0.00 | HK$0.02 | HK$0.02 | HK$0.02 |
| Shares | |||||
| Basic Shares Outstanding | 488.2M | 483.8M | 488.9M | 488.6M | 487.7M |
| Diluted Shares Outstanding | 488.2M | 483.8M | 488.9M | 488.6M | 487.7M |
| Profitability Metrics | |||||
| EBITDA | (41.0M) | (22.7M) | (19.0M) | (25.1M) | (30.6M) |
| D&A | 3.5M | 1.7M | 2.1M | 2.9M | 2.1M |
| EBIT | (44.5M) | (24.4M) | (21.1M) | (27.9M) | (32.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026